THC Farmaceuticals Statistics
Total Valuation
CBDG has a market cap or net worth of 310,050.
| Market Cap | 310,050 |
| Enterprise Value | n/a |
Important Dates
| Earnings Date | n/a |
| Ex-Dividend Date | n/a |
Share Statistics
CBDG has 18.13 million shares outstanding.
| Current Share Class | 18.13M |
| Shares Outstanding | 18.13M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | +0.17% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | n/a |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 16.74 |
| PB Ratio | 0.31 |
| P/TBV Ratio | 0.41 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.98, with a Debt / Equity ratio of 0.67.
| Current Ratio | 1.98 |
| Quick Ratio | 1.98 |
| Debt / Equity | 0.67 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -28.74 |
Financial Efficiency
Return on equity (ROE) is -14.87% and return on invested capital (ROIC) is -5.04%.
| Return on Equity (ROE) | -14.87% |
| Return on Assets (ROA) | -4.96% |
| Return on Invested Capital (ROIC) | -5.04% |
| Return on Capital Employed (ROCE) | -4.12% |
| Weighted Average Cost of Capital (WACC) | -18.20% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | 0.02 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +1.18% in the last 52 weeks. The beta is -11.50, so CBDG's price volatility has been lower than the market average.
| Beta (5Y) | -11.50 |
| 52-Week Price Change | +1.18% |
| 50-Day Moving Average | 0.03 |
| 200-Day Moving Average | 0.02 |
| Relative Strength Index (RSI) | 47.20 |
| Average Volume (20 Days) | 6,662 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 0.03 |
Income Statement
In the last 12 months, CBDG had revenue of 18,519 and -72,473 in losses. Loss per share was -0.01.
| Revenue | 18,519 |
| Gross Profit | 4,419 |
| Operating Income | -70,030 |
| Pretax Income | -72,473 |
| Net Income | -72,473 |
| EBITDA | -69,425 |
| EBIT | -70,030 |
| Loss Per Share | -0.01 |
Balance Sheet
The company has 30,551 in cash and 684,223 in debt, with a net cash position of -653,672 or -0.04 per share.
| Cash & Cash Equivalents | 30,551 |
| Total Debt | 684,223 |
| Net Cash | -653,672 |
| Net Cash Per Share | -0.04 |
| Equity (Book Value) | 1.01M |
| Book Value Per Share | 0.08 |
| Working Capital | 15,812 |
Cash Flow
| Operating Cash Flow | -1.51M |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
| Gross Margin | 23.86% |
| Operating Margin | -378.15% |
| Pretax Margin | -391.34% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
CBDG does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -50.42% |
| Shareholder Yield | -50.42% |
| Earnings Yield | -23.37% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
CBDG has an Altman Z-Score of 7.83.
| Altman Z-Score | 7.83 |
| Piotroski F-Score | n/a |